Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prenetics Global signs "transformational" $200mln deal to create cancer screening JV By: News Direct June 30, 2023 at 08:00 AM EDT --News Direct--Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its first CEO. Yeung reveals plans to launch tests targeting lung and liver cancer in 2025, with a goal of selling over 30 million tests annually by 2030.Contact DetailsProactive United StatesProactive United States+1 347-449-0879action@proactiveinvestors.comView source version on newsdirect.com: https://newsdirect.com/news/prenetics-global-signs-transformational-200mln-deal-to-create-cancer-screening-jv-764359654 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV By: News Direct June 30, 2023 at 08:00 AM EDT --News Direct--Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its first CEO. Yeung reveals plans to launch tests targeting lung and liver cancer in 2025, with a goal of selling over 30 million tests annually by 2030.Contact DetailsProactive United StatesProactive United States+1 347-449-0879action@proactiveinvestors.comView source version on newsdirect.com: https://newsdirect.com/news/prenetics-global-signs-transformational-200mln-deal-to-create-cancer-screening-jv-764359654
--News Direct--Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor Dennis Lo. The new JV will be called Insighta and Yeung will serve as its first CEO. Yeung reveals plans to launch tests targeting lung and liver cancer in 2025, with a goal of selling over 30 million tests annually by 2030.Contact DetailsProactive United StatesProactive United States+1 347-449-0879action@proactiveinvestors.comView source version on newsdirect.com: https://newsdirect.com/news/prenetics-global-signs-transformational-200mln-deal-to-create-cancer-screening-jv-764359654
